Document Detail


Bone marrow mesenchymal stem cells improve myocardial function in a swine model of acute myocardial infarction.
MedLine Citation:
PMID:  25060678     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
The aim of the current study was to confirm the effect and elucidate the mechanism of bone marrow mesenchymal stem cells (BMSCs) in acute myocardial infarction (AMI). AMI was induced in mini‑swine by ligating the left anterior descending coronary artery, and BMSCs (1x107) were injected via a sterile microinjection into the ischemic area. Six months postoperatively, electrocardiograph‑gated single photon emission computed tomography revealed that the myocardial filling defect was reduced and the left ventricular ejection fraction was improved in the BMSC group compared with the control group (P<0.05). Histopathological examination indicated that, in the BMSC treatment group, the percentage of survived myocardial tissue and the vessel density were increased, and the percentage of apoptosis was decreased compared with controls (P<0.05). Reverse transcription‑polymerase chain reaction results indicated that the expression levels of multiple inflammatory factors were significantly upregulated in the BMSC group compared with levels in the control group (P<0.05). In conclusion, the present study demonstrated that BMSC injection significantly improved cardiac function and reduced infarct size in six months, indicating that this method may be valuable for future study in clinical trials.
Authors:
Jing-Jie Zhao; Xiao-Cheng Liu; Feng Kong; Tong-Gang Qi; Guang-Hui Cheng; Jue Wang; Chao Sun; Yun Luan
Related Documents :
23982478 - Intramyocardial injection of autologous bone marrow-derived ex vivo expanded mesenchyma...
24117988 - Reproduction of continuous flow left ventricular assist device experimental data by mea...
9857948 - Optimal timing of phase ii rehabilitation after cardiac surgery. the cardiologist's view.
10149848 - Pediatric interventional cardiac catheterization.
14077808 - Effect of an aldosterone antagonist (spironolactone) on patients with severe congestive...
15218388 - Low-molecular-weight heparins in ischemic heart disease.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-7-14
Journal Detail:
Title:  Molecular medicine reports     Volume:  10     ISSN:  1791-3004     ISO Abbreviation:  Mol Med Rep     Publication Date:  2014 Sep 
Date Detail:
Created Date:  2014-7-25     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101475259     Medline TA:  Mol Med Rep     Country:  -    
Other Details:
Languages:  ENG     Pagination:  1448-1454     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Molecular ultrastructure of the urothelial surface: Insights from a combination of various microscop...
Next Document:  Detailed characterization of MLH1 p.D41H and p.N710D variants coexisting in a Lynch syndrome family ...